News | January 01, 2025
Anthem Biosciences files DRHP for Rs. 3,395 crore IPO
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated
